{"Efficacious": [0], "vaccines": [1], "are": [2, 116, 124], "urgently": [3], "needed": [4], "to": [5, 76, 249, 272, 299, 303, 310, 323, 334], "contain": [6], "the": [7, 57, 78, 133, 141, 144, 158, 164, 203, 212, 219, 240, 292, 326, 381, 389], "ongoing": [8], "coronavirus": [9, 21], "disease": [10], "2019": [11], "(Covid-19)": [12], "pandemic": [13], "of": [14, 59, 70, 84, 137, 143, 233, 252, 297, 325, 336, 366, 371, 388, 391], "infection": [15], "with": [16, 112, 264, 341], "severe": [17], "acute": [18], "respiratory": [19], "syndrome": [20], "2": [22], "(SARS-CoV-2).": [23], "A": [24, 285], "candidate": [25], "vaccine,": [26], "Ad26.COV2.S,": [27], "is": [28], "a": [29, 38, 82, 101, 109, 113, 265, 295, 342], "recombinant,": [30], "replication-incompetent": [31], "adenovirus": [32], "serotype": [33], "26": [34], "(Ad26)": [35], "vector": [36], "encoding": [37], "full-length": [39], "and": [40, 61, 66, 135, 154, 156, 174, 198, 258, 331, 363, 380, 385, 393], "stabilized": [41], "SARS-CoV-2": [42], "spike": [43], "protein.In": [44], "this": [45, 372], "multicenter,": [46], "placebo-controlled,": [47], "phase": [48], "1-2a": [49], "trial,": [50], "we": [51], "randomly": [52], "assigned": [53], "healthy": [54], "adults": [55], "between": [56], "ages": [58], "18": [60], "55": [62], "years": [63, 69], "(cohort": [64, 74], "1)": [65], "those": [67, 122, 200, 209, 337], "65": [68], "age": [71, 256], "or": [72, 90, 98, 103, 231, 255], "older": [73], "3)": [75], "receive": [77], "Ad26.COV2.S": [79, 367], "vaccine": [80, 146, 205, 242, 253, 373], "at": [81, 281], "dose": [83, 139, 147, 160, 206, 243, 254, 287], "5\u00d71010": [85], "viral": [86, 92], "particles": [87, 93], "(low": [88], "dose)": [89, 95], "1\u00d71011": [91], "(high": [94], "per": [96], "milliliter": [97], "placebo": [99], "in": [100, 119, 148, 151, 161, 191, 195, 199, 208, 229, 268, 274, 291, 321, 328, 332, 338, 359], "single-dose": [102, 110], "two-dose": [104, 114], "schedule.": [105], "Longer-term": [106], "data": [107], "comparing": [108], "regimen": [111, 115], "being": [117], "collected": [118], "cohort": [120, 162, 192, 196, 275, 329, 339, 360], "2;": [121], "results": [123], "not": [125], "reported": [126], "here.": [127], "The": [128, 177], "primary": [129], "end": [130], "points": [131], "were": [132, 170, 188, 227, 308, 319, 354], "safety": [134, 362], "reactogenicity": [136], "each": [138], "schedule.After": [140], "administration": [142], "first": [145, 241], "805": [149], "participants": [150, 235, 327], "cohorts": [152], "1": [153, 197, 330, 347], "3": [155, 193], "after": [157, 218, 239], "second": [159, 220, 286], "1,": [163], "most": [165, 178], "frequent": [166, 179], "solicited": [167], "adverse": [168, 181, 186], "events": [169, 187], "fatigue,": [171], "headache,": [172], "myalgia,": [173], "injection-site": [175], "pain.": [176], "systemic": [180], "event": [182], "was": [183, 216], "fever.": [184], "Systemic": [185], "less": [189], "common": [190], "than": [194, 207], "who": [201, 210], "received": [202, 211], "low": [204], "high": [213], "dose.": [214, 221], "Reactogenicity": [215], "lower": [217, 358], "Neutralizing-antibody": [222], "titers": [223, 269], "against": [224], "wild-type": [225], "virus": [226], "detected": [228, 320], "90%": [230], "more": [232], "all": [234], "on": [236], "day": [237, 262, 283, 314], "29": [238], "(geometric": [244], "mean": [245], "titer": [246, 293], "[GMT],": [247], "212": [248], "354),": [250], "regardless": [251], "group,": [257], "reached": [259], "96%": [260], "by": [261, 294, 376], "57": [263], "further": [266, 369], "increase": [267, 290], "(GMT,": [270, 301], "288": [271], "488)": [273], "1a.": [276], "Titers": [277], "remained": [278], "stable": [279], "until": [280], "least": [282], "71.": [284], "provided": [288], "an": [289], "factor": [296], "2.6": [298], "2.9": [300], "827": [302], "1266).": [304], "Spike-binding": [305], "antibody": [306], "responses": [307, 318, 353], "similar": [309], "neutralizing-antibody": [311], "responses.": [312], "On": [313], "15,": [315], "CD4+": [316], "T-cell": [317, 352], "76": [322], "83%": [324], "60": [333], "67%": [335], "3,": [340], "clear": [343], "skewing": [344], "toward": [345], "type": [346], "helper": [348], "T": [349], "cells.": [350], "CD8+": [351], "robust": [355], "overall": [356], "but": [357], "3.The": [361], "immunogenicity": [364], "profiles": [365], "support": [368], "development": [370], "candidate.": [374], "(Funded": [375], "Johnson": [377, 379], "&": [378], "Biomedical": [382], "Advanced": [383], "Research": [384], "Development": [386], "Authority": [387], "Department": [390], "Health": [392], "Human": [394], "Services;": [395], "COV1001": [396], "ClinicalTrials.gov": [397], "number,": [398], "NCT04436276.).": [399]}